Fast Five Quiz: Management of Cholangiocarcinoma

N. Joseph Espat, MD, MS

Disclosures

February 20, 2020

Even though the rates of resection with tumor-free margins have improved with more aggressive surgical approaches and improved radiologic techniques, recurrence rates remain high (49%-64%). These recurrences usually occur within 2-3 years post-resection and are predominantly intrahepatic.

Even after curative-intent resection of intrahepatic cholangiocarcinoma, the probability of cure is only about 10%. Up to 45% of patients with cholangiocarcinoma that is considered resectable actually have unresectable disease upon performance of explorative laparotomy. Contraindications to surgical resection include bilateral, multifocal disease; distant metastases; and comorbidities that increase operative risk.

Learn more about treatment and management in cholangiocarcinoma.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....